InxMed Co., Ltd. announced that IN10018, its focal adhesion kinase (FAK) inhibitor, had been granted with Breakthrough Therapy Designation by the China National Medical...
Juniper Biologics, a science-led healthcare company focused on researching, developing and commercializing novel therapies announced that it has gained the licensing rights to develop...
The Oklahoma Proton Center celebrated the graduation of its 4,000th patient. Mr. Eric Green was a 59-year-old prostate cancer patient who chose the Oklahoma...
Rockwell Medical, Inc., a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management, announced an expanded partnership with DaVita Inc.,...
Debiopharm, an oncology and infectious disease focused biopharmaceutical company based in Switzerland, today announced data releases on 3 investigational products including Debio 0123 (Selective...
